Q1 2026: Psychedelic Drug Development Pipeline Bullseye Charts

Psychedelic Alpha presents Q1 2026 bullseye charts for the psychedelic drug development pipeline. The resource is segmented in two ways: by molecule group and by indication grouping. This framing helps readers compare where psychedelics development is concentrated across different chemical categories and across target disease or condition areas. A high-resolution PDF version is available via newsletter signup, positioning the charts as a regularly updated, data-driven snapshot of pipeline activity entering 2026.